Autonomic Nervous System Drugs Practice Questions

Q: Which of the following is a directly acting skeletal muscle relaxant?

Dantrolene. **Explanation:** The question tests the classification of skeletal muscle relaxants based on their site of action. **1. Why Dantrolene is Correct:** Dantrolene is the only **directly acting** skeletal muscle relaxant among the options. Unlike others that act at the neuromuscular junction (NMJ), Dantrolene acts intracellularly within the muscle fiber. It binds to the **Ryanodine Receptor (RyR1)** on the sarcoplasmic reticulum, inhibiting the release of calcium ions into the sarcoplasm. Since calcium is essential for excitation-contraction coupling, its blockade leads to muscle relaxation. **2. Why Other Options are Incorrect:** * **Suxamethonium (Succinylcholine):** It is a **depolarizing neuromuscular blocker**. It acts on the nicotinic receptors ($N_m$) at the NMJ, causing persistent depolarization of the motor endplate. * **Pancuronium & Atracurium:** These are **non-depolarizing (competitive) neuromuscular blockers**. They act by competing with Acetylcholine for the $N_m$ receptors at the NMJ, preventing muscle contraction. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** Dantrolene is the life-saving drug of choice for **Malignant Hyperthermia** (often triggered by Halothane or Suxamethonium) and **Neuroleptic Malignant Syndrome (NMS)**. * **Atracurium:** Notable for undergoing **Hofmann Elimination** (spontaneous non-enzymatic degradation), making it safe in patients with liver or kidney failure. * **Suxamethonium:** Associated with muscle fasciculations, hyperkalemia, and post-operative myalgia. It is metabolized by **pseudocholinesterase**.

Q: Oximes are not useful in the management of which type of poisoning?

Carbamate poisoning (e.g., Carbaryl). The primary mechanism of **Oximes** (e.g., Pralidoxime/PAM) is to reactivate the enzyme **Acetylcholinesterase (AChE)** that has been inactivated by phosphorylation [1]. **Why Carbamates are the correct answer:** In **Carbamate poisoning** (e.g., Carbaryl, Neostigmine), the enzyme AChE undergoes "carbamylation" rather than phosphorylation [2]. This carbamylation is **spontaneously reversible** and occurs rapidly [2]. Oximes are not useful here because: 1. The carbamylated enzyme does not respond to oximes. 2. Oximes themselves have weak anticholinesterase activity; adding them can potentially worsen the clinical blockade. *Note: An exception is Propanil/Carbaryl where oximes are strictly contraindicated, though in clinical practice, they are generally avoided for all carbamates.* **Why the other options are incorrect:** * **Options A, C, and D (Parathion, Malathion, Phosmet):** These are all **Organophosphates (OPs)** [3]. OPs cause irreversible inhibition of AChE by phosphorylation [1, 2]. Oximes work by dephosphorylating the enzyme, provided they are administered before "aging" (the permanent chemical bond formation) occurs [1]. Therefore, oximes are a standard part of the treatment protocol for these agents. **High-Yield Clinical Pearls for NEET-PG:** * **Atropine** is the drug of choice for both OP and Carbamate poisoning (it treats the muscarinic symptoms). * **Oximes** are specific for OP poisoning but must be given early (within 24–48 hours) before **"Aging"** of the enzyme occurs [1]. * **Soman** is an OP nerve gas that "ages" extremely rapidly (within minutes), making oximes clinically ineffective [2]. * **Signs of Atropinization:** Mydriasis, tachycardia, and cessation of secretions (dry skin/mouth).

Q: Ipratropium bromide is contraindicated in which of the following conditions?

Urinary retention. **Explanation:** **Ipratropium bromide** is a short-acting muscarinic antagonist (SAMA). It works by blocking M3 receptors on smooth muscles, leading to bronchodilation and decreased secretions [3]. **Why Urinary Retention is the Correct Answer:** Muscarinic antagonists exert systemic anticholinergic effects. In the bladder, M3 receptors are responsible for the contraction of the **detrusor muscle** and relaxation of the sphincter to facilitate voiding. By blocking these receptors, Ipratropium can cause detrusor relaxation and increased sphincter tone, significantly worsening pre-existing **urinary retention** (especially in patients with Benign Prostatic Hyperplasia) [2], [4]. While Ipratropium is administered via inhalation to limit systemic absorption, enough can be absorbed to trigger these adverse effects in susceptible individuals. **Analysis of Incorrect Options:** * **A. Asthma:** This is a primary **indication**, not a contraindication [1]. Ipratropium is used as an adjunctive bronchodilator in acute asthma exacerbations. * **C. Hypertension:** Anticholinergics generally do not have a significant impact on blood pressure; they are more likely to cause tachycardia. It is not a contraindication. * **D. Peptic Ulcer:** Anticholinergics actually reduce gastric acid secretion (M1 blockade). While not a primary treatment for PUD today, they are certainly not contraindicated. **NEET-PG High-Yield Pearls:** * **Chemistry:** Ipratropium is a **quaternary ammonium compound**, meaning it is highly polar, does not cross the blood-brain barrier, and has poor systemic absorption compared to atropine [4]. * **Glaucoma Warning:** Use with caution in **narrow-angle glaucoma**, as it can increase intraocular pressure if the drug accidentally sprays into the eyes [2]. * **Drug of Choice:** Ipratropium/Tiotropium are the drugs of choice for **COPD** (more effective than beta-2 agonists in these patients) [1].

Q: What is the mechanism of action of Silodosin?

Alpha antagonist. **Explanation:** **Silodosin** is a highly selective **alpha-1A (α1A) adrenergic receptor antagonist**. These receptors are primarily located in the smooth muscles of the prostate, bladder neck, and prostatic urethra. By blocking these receptors, Silodosin induces smooth muscle relaxation, which reduces resistance to urine flow and alleviates the dynamic component of urinary obstruction in patients with **Benign Prostatic Hyperplasia (BPH)**. **Analysis of Options:** * **Option A (Correct):** Silodosin belongs to the class of uroselective alpha-blockers. Unlike older agents like Doxazosin, Silodosin is highly specific for the α1A subtype, minimizing systemic side effects like hypotension. * **Option B:** Beta-antagonists (Beta-blockers) are used for hypertension, arrhythmias, and heart failure; they have no role in relaxing prostatic smooth muscle. * **Option C:** Anticholinergics (e.g., Oxybutynin) are used for overactive bladder. In BPH, they are generally avoided as monotherapy because they can decrease detrusor contraction and precipitate acute urinary retention. * **Option D:** PDE5 inhibitors (e.g., Tadalafil) can be used for BPH, but their mechanism involves increasing cGMP levels to relax smooth muscle, not alpha-receptor blockade. **NEET-PG High-Yield Pearls:** 1. **Uroselectivity:** Silodosin is more selective for α1A than Tamsulosin, leading to the lowest incidence of orthostatic hypotension among alpha-blockers. 2. **Side Effect:** The most characteristic side effect of Silodosin is **retrograde ejaculation** (due to relaxation of the vas deferens and ejaculatory duct). 3. **IFIS:** Like Tamsulosin, Silodosin is associated with **Intraoperative Floppy Iris Syndrome (IFIS)** during cataract surgery. Patients should be screened before surgery.

Q: Pilocarpine is a:

Muscarinic cholinergic drug. **Explanation:** **Pilocarpine** is a naturally occurring alkaloid derived from the leaves of *Pilocarpus microphyllus*. It acts as a **direct-acting cholinomimetic** that primarily stimulates **muscarinic (M1, M2, M3) receptors**. 1. **Why Option A is Correct:** Pilocarpine has a dominant effect on muscarinic receptors, particularly the **M3 receptors** found in exocrine glands and smooth muscles. When applied to the eye, it causes contraction of the sphincter pupillae (miosis) and the ciliary muscle (accommodation), which facilitates the drainage of aqueous humor. 2. **Why Other Options are Incorrect:** * **Option B:** While some cholinergic drugs (like Nicotine or Varenicline) target nicotinic receptors at the ganglia or neuromuscular junction, Pilocarpine has negligible action on nicotinic receptors at therapeutic doses. * **Options C & D:** Alpha and Beta-adrenergic drugs belong to the Sympathetic Nervous System (e.g., Adrenaline, Phenylephrine). Pilocarpine belongs to the Parasympathetic (Cholinergic) system and does not interact with adrenergic receptors. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Pilocarpine is the DOC for **Acute Angle-Closure Glaucoma** (administered as 0.5%–4% drops) to rapidly lower intraocular pressure. * **Sjögren’s Syndrome/Xerostomia:** Oral pilocarpine is used to increase salivation and lacrimation. * **Ciliary Muscle Contraction:** Unlike sympathomimetics, pilocarpine causes "spasm of accommodation" (false myopia) because it contracts the ciliary muscle. * **Sweat Test:** It is used via iontophoresis to induce sweating for the diagnosis of **Cystic Fibrosis**.

Q: Dicyclomine is a

Anticholinergic drug. **Explanation:** **Dicyclomine** is a synthetic tertiary amine compound that acts as a **competitive antagonist at muscarinic (M3) receptors**. By blocking these receptors, it inhibits the action of acetylcholine on smooth muscles, leading to its classification as an **Anticholinergic drug** (specifically an antispasmodic). * **Why Option C is Correct:** Dicyclomine exerts direct relaxant effects on the smooth muscles of the gastrointestinal tract. It reduces GI motility and secretions, making it a first-line agent for treating functional bowel disorders like **Irritable Bowel Syndrome (IBS)**. * **Why Option A is Incorrect:** Cholinergic drugs (parasympathomimetics) mimic acetylcholine. These would increase GI motility and cramping, which is the opposite of dicyclomine’s effect. * **Why Options B & D are Incorrect:** Adrenergic and anti-adrenergic drugs act on the sympathetic nervous system (alpha and beta receptors). Dicyclomine has no significant affinity for these receptors. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mechanism:** It possesses dual action—antimuscarinic activity and direct non-specific smooth muscle relaxation (musculotropic action). 2. **Clinical Use:** Primarily used in **IBS** and **spastic colon**. 3. **Contraindications:** Like all anticholinergics, it is contraindicated in patients with **Glaucoma** (increases intraocular pressure), **Prostatic Hypertrophy** (causes urinary retention), and **Myasthenia Gravis**. 4. **Side Effects:** Common "atropine-like" effects include dry mouth, blurred vision, and tachycardia.

Q: Dale's vasomotor reversal is due to which of the following?

Alpha blocker. **Explanation:** **Dale’s Vasomotor Reversal** (or the Dale Phenomenon) is a classic pharmacological observation involving the biphasic response of blood pressure to Adrenaline (Epinephrine). 1. **Mechanism of the Correct Answer (Alpha Blocker):** Adrenaline acts on both **α-receptors** (causing vasoconstriction and rise in BP) and **β2-receptors** (causing vasodilation and fall in BP). Normally, the α-effect is dominant, leading to a net rise in blood pressure. However, if an **α-blocker** (e.g., Phentolamine or Ergot alkaloids) is administered beforehand, the α-mediated vasoconstriction is abolished. This "unmasks" the pure β2-mediated vasodilation, causing the blood pressure to fall instead of rise. This reversal of the pressor response to a depressor response is Dale's Vasomotor Reversal. 2. **Why Other Options are Incorrect:** * **Beta blockers:** If a β-blocker is given, the β2-mediated vasodilation is blocked. This leads to an "exaggerated" pressor response (higher rise in BP) because the α-effect is now unopposed. * **Acetylcholine inhibitor:** Dale’s phenomenon is specific to adrenergic receptors and the sympathetic nervous system; it does not involve the cholinergic system or Acetylcholine. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Dale’s reversal is most commonly demonstrated using **Phentolamine** (non-selective α-blocker). * **Selective α1-blockers:** Drugs like Prazosin also produce this effect. * **Noradrenaline:** Does **not** show Dale’s reversal because it has negligible action on β2 receptors; it only causes a rise in BP or a return to baseline. * **Clinical Significance:** This explains why α-blockers are used first in Pheochromocytoma to prevent a hypertensive crisis from unopposed α-stimulation.

Q: How would a drug that competes with acetylcholine (ACh) for receptors at the motor end plate affect skeletal muscle?

Cause muscles to relax and be unable to contract. ### Explanation **1. Why the Correct Answer is Right:** The drug described is a **competitive (non-depolarizing) neuromuscular blocker**, such as **d-Tubocurarine** or **Vecuronium** [1]. These drugs act as antagonists at the **Nicotinic-M ($N_M$) receptors** located on the motor end plate of skeletal muscles [2]. By competing with Acetylcholine (ACh) for these receptor sites, they prevent ACh from binding. Since ACh cannot bind, the sodium channels do not open, the end-plate potential is not generated, and the muscle remains in a state of **flaccid paralysis** (relaxed and unable to contract) [3]. **2. Why the Incorrect Options are Wrong:** * **Option A & B:** These describe the effects of excessive cholinergic stimulation or **depolarizing blockers** (like Succinylcholine) in their initial phase [5]. If a drug were an *agonist* or an *Acetylcholinesterase inhibitor* (like Neostigmine), it would cause persistent depolarization, leading to spasms or "spastic" paralysis [1]. * **Option D:** A competitive antagonist *decreases* excitability by raising the threshold required for a nerve impulse to trigger a contraction. **3. NEET-PG Clinical Pearls & High-Yield Facts:** * **Reversibility:** The blockade caused by competitive blockers can be reversed by increasing the concentration of ACh. This is clinically achieved using **Acetylcholinesterase inhibitors** (e.g., **Neostigmine**) [1]. * **Sequence of Paralysis:** Small, rapidly moving muscles (eyes, fingers) are paralyzed first, followed by limbs, trunk, and finally the **diaphragm**. Recovery occurs in the reverse order. * **Drug of Choice:** **Rocuronium** is often preferred for rapid sequence intubation when Succinylcholine is contraindicated [4]. * **Sugammadex:** A novel reversal agent specifically for Rocuronium and Vecuronium that encapsulates the drug molecules, rendering them inactive.

Question 1

Which of the following is a directly acting skeletal muscle relaxant?

Accepted Answer

Dantrolene

Answer

Suxamethonium

Answer

Pancuronium

Answer

Atracurium

Question 2

Oximes are not useful in the management of which type of poisoning?

Accepted Answer

Carbamate poisoning (e.g., Carbaryl)

Answer

Organophosphate poisoning (e.g., Parathion)

Answer

Organophosphate poisoning (e.g., Malathion)

Answer

Organophosphate poisoning (e.g., Phosmet)

Question 3

Ipratropium bromide is contraindicated in which of the following conditions?

Accepted Answer

Urinary retention

Answer

Asthma

Answer

Hypertension

Answer

Peptic ulcer

Question 4

What is the mechanism of action of Silodosin?

Accepted Answer

Alpha antagonist

Answer

Beta antagonist

Answer

Anticholinergic

Answer

PDE5 inhibitor

Question 5

Pilocarpine is a:

Accepted Answer

Muscarinic cholinergic drug

Answer

Nicotinic cholinergic drug

Answer

Alpha-adrenergic drug

Answer

Beta-adrenergic drug

Question 6

Dicyclomine is a

Accepted Answer

Anticholinergic drug

Answer

Cholinergic drug

Answer

Adrenergic drug

Answer

Anti-adrenergic drug

Question 7

Dale's vasomotor reversal is due to which of the following?

Accepted Answer

Alpha blocker

Answer

Beta blocker

Answer

Acetylcholine inhibitor

Answer

All of the above

Question 8

How would a drug that competes with acetylcholine (ACh) for receptors at the motor end plate affect skeletal muscle?

Accepted Answer

Cause muscles to relax and be unable to contract

Answer

Produce uncontrolled muscle spasms

Answer

Cause the muscles to contract and be unable to relax

Answer

Make the muscles more excitable

Question 9

Which of the following statements regarding 5-HT derivatives is true?

Accepted Answer

Sumatriptan's action is mediated by agonistic 5-HT 1B/1D receptor activity

Answer

Cisapride is a selective 5-HT4 antagonist

Answer

Ondansetron is a 5-HT3 agonist

Answer

Cyproheptadine is a 5-HT2A agonist

Question 10

Glycogenolysis is mediated by which receptors?

Accepted Answer

Alpha 1 and Beta 2 receptors

Answer

Alpha 1 receptor

Answer

Beta 2 receptor

Answer

Alpha 2 and Beta 1 receptors

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?